This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Daiichi Sankyo Company, Limited, Ube Industries, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016
Title: Innovator Yukinori Kawai: Pioneering Pyridine Compounds in Tokyo
Introduction
Yukinori Kawai is a notable inventor based in Tokyo, Japan, recognized for his contributions to the field of medicinal chemistry. His innovative spirit has led to the development of a unique compound that holds promise for therapeutic use.
Latest Patents
Kawai holds a patent for an "Acid addition salt of substituted pyridine compound". This invention provides a salt of a substituted pyridine compound that exhibits significant CETP inhibition activity, making it a valuable medicament for potential use in treating various health conditions. The compound is represented by a general formula that allows for optional substitutions, enhancing its versatility and applicability.
Career Highlights
Throughout his career, Yukinori Kawai has made substantial impacts while working at prestigious companies such as Daiichi Sankyo Company, Limited and Ube Industries, Inc. His role at these organizations has significantly contributed to the advancement of drug development and innovation within the pharmaceutical industry.
Collaborations
In his journey as an inventor, Kawai has collaborated with esteemed coworkers, including Noriaki Iwase and Osamu Kikuchi. These partnerships have enabled him to combine expertise and knowledge in developing groundbreaking inventions.
Conclusion
Yukinori Kawai continues to be a significant figure in the realm of pharmaceutical innovations. With his patent on the substituted pyridine compound, he exemplifies how inventive thinking and collaboration can lead to advancements that impact health and medicine. His work not only enhances our understanding but also sets the stage for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile